Goldman Sachs Maintains Buy on Xylem, Lowers Price Target to $138

Benzinga · 4d ago
Goldman Sachs analyst Brian Lee maintains Xylem (NYSE:XYL) with a Buy and lowers the price target from $160 to $138.